Last updated: October 8, 2023
Sponsor: HaEmek Medical Center, Israel
Overall Status: Active - Recruiting
Phase
N/A
Condition
Labor/delivery
Treatment
glucose solution only
glucose solution and Insulin
Clinical Study ID
NCT03273881
0056-17-EMC
Ages 18-60 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- >37 weeks gestation
- gestational diabetes mellitus according to Carpenter and Coustan
- pregestational diabetes mellitus
Exclusion
Exclusion Criteria:
- Intrauterine fetal death
- estimated fetal weight<10p
- multiple gestation
- major fetal malformations
Study Design
Total Participants: 200
Treatment Group(s): 2
Primary Treatment: glucose solution only
Phase:
Study Start date:
October 31, 2017
Estimated Completion Date:
December 31, 2023
Study Description
Connect with a study center
HaEmek medical center
Afula, 18101
IsraelActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.